- ►bmj.com SL Johnston, RJ Lock, MM Gompels - British Medical Journal, 2002 - jcp.bmj.com Takayasu arteritis, also known as pulseless disease, occlusive
thromboaortopathy, and Martorell syndrome, 1 is a chronic inflammatory arteritis
affecting large vessels, predominantly the aorta and its main branches. ... Cited by 197 - Related articles - BL Direct - All 7 versions
P Liang, GS Hoffman - Current opinion in rheumatology, 2005 - journals.lww.com Purpose of review Takayasu arteritis remains a therapeutic challenge. In spite
of current treatments, progression of vascular lesions is observed frequently.
The purpose of this article is to describe advances in therapeutic ... Cited by 62 - Related articles - All 4 versions
C Gordon - Best Practice & Research Clinical Rheumatology, 2004 - Elsevier Until about 15 years ago, the general advice to women with autoimmune rheumatic
diseases, especially systemic lupus erythematosus, systemic sclerosis and
vasculitic syndromes, was to avoid pregnancy as there was a high risk of ... Cited by 45 - Related articles - All 17 versions
BP Mwipatayi, PC Jeffery, SJ Beningfield, PJ … - ANZ journal of surgery, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 44 - Related articles - All 3 versions
Y Huang, Z Liu, H Huang, H Liu, L Li - International immunopharmacology, 2005 - Elsevier Mycophenolate mofetil (MMF) is a potent immunosuppressant that inhibits the
activity of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting
enzyme in de novo synthesis of guanosine nucleotides. MMF has been used ... Cited by 40 - Related articles - All 3 versions
C Zoja, A Benigni, M Noris, D Corna, F … - Kidney international, 2001 - nature.com Approaches to the treatment of lupus nephritis include immunosuppressants
associated with anti-inflammatory drugs, mainly steroids, which, however, cause
major side effects. Mycophenolate mofetil (MMF) has been described as being ... Cited by 40 - Related articles - BL Direct - All 4 versions
EM Frohman, K Brannon, MK Racke, K … - Clinical neuropharmacology, 2004 - journals.lww.com Background: MMF is a potent immunosuppressant that is a selec- tive inhibitor of
inosine 5-monophosphate dehydrogenase type II, the enzyme responsible for the de
novo synthesis of the purine nucleo- tide guanine within activated T and B ... Cited by 37 - Related articles - BL Direct - All 3 versions
P Seo, JH Stone - Arthritis and Rheumatism-Arthritis Care and Research, 2004 - uth.tmc.edu Introduction The vasculitides and their treatments pose great risks for patients
and difficult challenges for physicians. Clinicians are confronted with the task
of treating diseases for which the understanding of pathophysiology is ... Cited by 37 - Related articles - View as HTML - BL Direct - All 6 versions
- ►oxfordjournals.org J Andrews, JC Mason - Rheumatology, 2007 - Br Soc Rheumatology Takayasu's arteritis (TA), a rare large vessel vasculitis of unknown aetiology,
remains a difficult disease to manage with diagnosis often delayed until the
late occlusive stage when irreversible vascular damage has occurred. Recent ... Cited by 35 - Related articles - BL Direct - All 5 versions
V Liu, BT Mackool - Journal of Dermatological Treatment, 2003 - informahealthcare.com As many dermatoses are increasingly being recognized as products of immunologic
dysregulation, immunosup- pressive agents have come to the forefront of the
derma- tologic armamentarium. Undeniably, the introduction of ... Cited by 31 - Related articles - BL Direct - All 5 versions
